Squawk on the Street Squawk on the Street

11AM Hour: Morgan Stanley CEO, Merck CEO & Former NEC Director Gary Cohn 10/14/26

Oct 14, 2026 · 46m

Summary

Squawk on the Street covers a hot September CPI report and its implications for the Fed, featuring former NEC Director Gary Cohn who argues against an imminent rate hike. Morgan Stanley CEO Ted Pick discusses the bank’s strong earnings and the enduring AI supercycle, while Merck’s CEO Rob Davis highlights new AI-driven R&D facilities and cancer vaccine progress. The show also analyzes ASML’s results, rising mortgage rate forecasts, and new data on the growing wealth gap between older and younger American households.

Topics discussed

Sponsor: Schwab Market Update Show intro: Hot CPI and Morgan Stanley earnings Market rotation and bond market reaction to CPI Bank earnings: Healthy consumer and labor market Fed outlook: Rate hike odds and market indecisiveness Normalization shock: Rates, GDP, and AI re-rating AI investment returns and corporate margin pressure Labor efficiency and fiscal implications of split government Government debt, Social Security, and AI productivity Tax policy and capital investment strategies Market caution and fixed income alternatives Sponsor: WISE Morgan Stanley CEO Ted Pick: AI and geopolitics Morgan Stanley outlook: Sentiment and Q4 optimism AI capex cycle and Morgan Stanley's advisory role Digital transformation and IPO window analysis Unicorns, cost of capital, and risk management Wealth management flows and barbell strategy Sponsor: WISE ASML earnings: Demand outstripping supply Semiconductor sector slump and China restrictions Mortgage rates and housing market impact News: Venezuela sanctions and Lincoln Memorial damage Household wealth divide and stock ownership trends Generational wealth gaps and prediction markets Fed Governor Lisa Cook fraud allegations hearing Merck CEO: New R&D facility and AI in drug discovery Merck: Personalized cancer vaccine with Moderna Merck: Vaccine supply and manufacturing timelines Merck: Keytruda subcutaneous launch and patent cliff Merck: $70B sales target and pipeline strategy Midterm elections: Republican ad spend and rallies Midterm strategy: Triage and local vs national issues Market levels, PPI, and closing remarks
Listen ad-free on Castria